SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-106456
Filing Date
2021-08-16
Accepted
2021-08-16 17:09:45
Documents
99
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1866621
2 EXHIBIT 31.1 tmb-20210630xex31d1.htm EX-31.1 9875
3 EXHIBIT 31.2 tmb-20210630xex31d2.htm EX-31.2 9843
4 EXHIBIT 32 tmb-20210630xex32.htm EX-32 6920
  Complete submission text file 0001104659-21-106456.txt   8632959

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210630.xsd EX-101.SCH 96143
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210630_cal.xml EX-101.CAL 65570
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210630_def.xml EX-101.DEF 214458
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210630_lab.xml EX-101.LAB 612187
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210630_pre.xml EX-101.PRE 459545
10 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 1582601
Mailing Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015
Business Address 5301 WISCONSIN AVENUE NW SUITE 570 WASHINGTON DC 20015 301-215-7440
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 211179661
SIC: 2834 Pharmaceutical Preparations